Acetazolamide for injection USP is indicated for adjunctive treatment of: edema due to congestive heart failure; drug-induced edema; centrencephalic epilepsies (petit mal, unlocalized seizures); chronic simple (open-angle) glaucoma, secondary glaucoma, and preoperatively in acute angle-closure glaucoma where delay of surgery is desired in order to lower intraocular pressure.
Acetazolamide for injection USP is supplied as a sterile, preservative-free lyophilized powder. Each vial contains acetazolamide sodium equivalent to 500mg of acetazolamide.
Susan Badia, X-Gen’s president and CEO, said: “Currently there is only one supplier of Acetazolamide for injection USP. Our launch of this product will ensure consistent supply and steady, competitive price levels. We look forward to serving the healthcare community as the preferred source for Acetazolamide for injection USP.”